# Improved Induction and Maintenance Immunosuppression in Kidney Transplantation

> **NCT00556933** · PHASE4 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 180 (actual)

## Conditions studied

- End-stage Renal Disease

## Interventions

- **DRUG:** rabbit anti-thymocyte globulin - single dose
- **DRUG:** mycophenolate mofetil
- **DRUG:** rabbit anti-thymocyte globulin - 4 doses
- **DRUG:** sirolimus
- **DRUG:** tacrolimus

## Key facts

- **NCT ID:** NCT00556933
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04-01
- **Primary completion:** 2011-04-01
- **Final completion:** 2011-06-01
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2023-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00556933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00556933, "Improved Induction and Maintenance Immunosuppression in Kidney Transplantation". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00556933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*